Enliven Therapeutics
ELVN
#5377
Rank
โ‚ฌ1.05 B
Marketcap
21,62ย โ‚ฌ
Share price
-1.75%
Change (1 day)
60.48%
Change (1 year)

Enliven Therapeutics (ELVN) - Cash on Hand

Cash on Hand as of September 2024 : โ‚ฌ0.28 Billion

According to Enliven Therapeutics's latest financial reports the company has โ‚ฌ0.28 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Enliven Therapeutics - Cash on Hand chart (from 2021 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31โ‚ฌ0.22 B225.2%
2022-12-31โ‚ฌ70.41 M-27.52%
2021-12-31โ‚ฌ97.15 M-8.34%
2020-12-31โ‚ฌ0.10 B